Skip to main content

Table 6 Univariate Cox regression model of clinical parameters on disease specific survival in stratified high-grade serous carcinoma (HGSC)

From: Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers

 

All HGSC

Advanced stage HGSC

Poor prognosis HGSC

Low Stage HGSC

Hazard

95.0% CI

  

Hazard

95.0% CI

  

Hazard

95.0% CI

  

Hazard

95.0% CI

  

Ratio

Lower

Upper

n

p value

Ratio

Lower

Upper

n

p value

Ratio

Lower

Upper

n

p value

Ratio

Lower

Upper

n

p value

BRCA mutation carrier statusa

 Non carrier

   

351

reference

   

293

reference

   

236

reference

   

61

reference

 BRCA1 carrier

0.62

0.44

0.88

67

0.007

0.65

0.44

0.95

45

0.029

0.79

0.51

1.20

32

0.268

0.92

0.40

2.11

21

0.849

 BRCA2 carrier

0.42

0.24

0.72

34

0.002

0.41

0.22

0.76

26

0.004

0.39

0.20

0.77

21

0.006

0.80

0.19

3.44

7

0.766

 All mutated vs no mutation

0.56

0.42

0.76

472

0.000

0.57

0.41

0.80

375

0.001

0.64

0.44

0.93

294

0.02

0.82

0.37

1.81

85

0.78

Chemotherapy treatment type

 Carboplatinum+taxane

   

940

reference

   

727

reference

   

469

reference

   

167

reference

 Cisplatinum+taxane

1.14

0.87

1.50

71

0.348

0.63

0.44

0.89

67

0.728

1.11

0.83

1.49

60

0.495

NA

NA

NA

4

NA

 Platinum

1.86

1.37

2.52

63

0.000

0.42

0.24

0.73

46

0.000

2.65

1.83

3.83

38

0.000

1.65

0.71

3.84

13

0.245

 Platinum+other

1.93

1.35

2.75

38

0.000

0.56

0.42

0.76

33

0.005

1.44

0.94

2.19

28

0.093

NA

NA

NA

3

NA

Provinces

 Quebec

   

584

reference

   

472

reference

   

275

reference

 

Lower

Upper

NA

 

 Ontario

0.80

0.66

0.98

195

0.034

0.69

0.54

0.88

119

0.003

0.77

0.58

1.03

89

0.074

NA

NA

NA

NA

NA

 Alberta

0.71

0.56

0.91

120

0.007

0.73

0.56

0.96

88

0.025

0.51

0.34

0.78

41

0.002

NA

NA

NA

NA

NA

 Manitoba

0.46

0.15

1.45

10

0.185

0.20

0.03

1.45

7

0.111

NA

NA

NA

6

NA

NA

NA

NA

NA

NA

 British Columbia

0.99

0.84

1.17

307

0.917

1.02

0.86

1.21

248

0.841

1.21

0.99

1.47

210

0.064

NA

NA

NA

NA

NA

  1. Bold values highlights the statistically significant difference with the reference category
  2. NA non applicable, number of cases too low, n number of patients with follow-up, HR Hazard ratio
  3. a platinum-based patients only, low stage: disease stage I and II, advanced stage: disease stage III and IV